Stay updated on Nivolumab vs. Everolimus in RCC: Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs. Everolimus in RCC: Clinical Trial page.

Latest updates to the Nivolumab vs. Everolimus in RCC: Clinical Trial page
- Check2 days agoChange DetectedA recruitment status notice ('No longer looking for participants') and new help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added. Minor formatting change of the Intervention/Treatment label and a revision tag update to v3.6.0 were applied.SummaryDifference0.2%

- Check9 days agoChange DetectedThe page's revision has been updated from v3.5.4 to v3.5.5, indicating a newer build of the page template. There is no change to the study content or visible data.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.5.4 was added and v3.5.3 was removed, indicating a small update to the page's revision history.SummaryDifference0.0%

- Check52 days agoChange DetectedThis updates the displayed ClinicalTrials.gov site revision/version label from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check60 days agoChange DetectedAdded collaborator Ono Pharmaceutical Co., Ltd.; removed Ono Pharmaceutical Co. Ltd. Revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check89 days agoChange DetectedThe page now shows Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Nivolumab vs. Everolimus in RCC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs. Everolimus in RCC: Clinical Trial page.